Primary Biliary Cirrhosis (Pbc) Treatment Market By Drug Type (Ursodeoxycholic Acid, Obeticholic Acid, Corticosteroids, Methotrexate); By Surgery (Liver Transplant); By Diagnosis Test (Blood Test, Imaging, Liver Biopsy) & By Geography - Forecast(2018 - 2023)

Primary biliary cirrhosis, also known as primary biliary cholangitis (PBC), is an autoimmune disease of the liver which is relatively rare as compared to other gastro diseases. The advanced stage of PBC is considered as cirrhosis. Identification, diagnosis and treatment differ based on the severity of PBC and patients’ condition. Several diagnosis tests are recommended including blood tests, imaging tests and liver biopsy which further encompass several test methods. The treatment includes medication approach as well as surgical approach. Medical approach includes employment of approved drugs individually or in combination including Ursodeoxycholic Acid, Corticosteroids and Methotrexate which are marketed under different brand names. Obeticholic Acid, new drug is under clinical trials and is expected to be launched in the near future.

Request Sample

The growth of this market is primarily attributed to increasing availability of treatment services and drugs. In addition, to drugs, liver transplantation is performed which completely prevents PBC.
 
Establishment of diagnosis and treatment standards in the recent years boosts the overall service experience as well as treatment outcomes which propels the market growth. Driven by the aforementioned factors, this market is set to reach $XX billion by 2021, growing at a CAGR of XX% during 2016-2021.




North America held a major share of XX% in the PBC drugs market, followed by Europe and APAC. Commercialization of new drugs and expanding specialized services for liver in India and China is set to boost the market revenue in APAC region.

The key players in the PBC Drugs market include:

Sanofi S.A.
Intercept Pharmaceuticals, Inc.
Mylan N.V.
Mankind Pharmaceuticals Pvt. Ltd.

We also publish more than 100 reports every month in "Lifesciences and Healthcare", Go through the Domain if there are any other areas for which you would like to get a market research study.
Location: United States

Comments

Post a Comment

Popular posts from this blog

Thermoplastic Vulcanizates Market - Forecast(2022 - 2027)

Thermoplastic vulcanizates market size is forecast to reach $1.5 billion by 2026, after growing at a CAGR of 5% during 2021-2026. Thermoplastic vulcanizates are based on polyvinylidene fluoride, acrylic rubber, and ethylene-methacrylic acid possess excellent chemical resistance to acids, bases, and other aqueous media, and have good property retention owing to which it is widely utilized in various end-use industries such as automotive, building & construction, sports, and more. In addition, thermoplastic vulcanizates deliver superior performance as compared to other substitute products such as conventional thermosetting rubbers owing to their special microstructure. Furthermore, the rapid growth of the medical & healthcare industry has increased the demand for thermoplastic vulcanizates; thereby, fueling market growth. Furthermore, the flourishing automotive & transportation industry is also anticipated to drive the thermoplastic vulcanizates industry substantially during...
Read more

Plasterboard Market - Forecast(2022 - 2027)

According to Eurogypsum, more than 1,600 million square meters of interior surfaces are covered with plasterboards with around 5 million tons of plaster used for interior lining in Europe each year. Similarly, owing to the on-going construction and intermittent replacement of the old plasterboards with the new ones across the globe, the plasterboard market has attained a permanent demand influx from various sectors, and its market size was $19,754 million in 2018, according to the findings by IndustryARC’s market analyst. Furthermore, the analyst estimates the demand for plasterboard to grow with a modest CAGR of 4.6% during the forecast period of 2019 to 2025.     According to the United Nations ESCAP (UNESCAP), in 2013, 60% of the world’s population was attributed to APAC which translates to a whopping 4.3 billion. Even though the organization estimates that the population will observe a growth rate of 0.96% year on year, the population will shoot up to around 5 billion...
Read more